Alkermes Ready To More Aggressively Pursue Deals After Oncology Spin-Out

Mural Oncology Launched In November

 
• By Mandy Jackson

After Alkermes spun out its oncology assets into a separate public entity so the company could focus exclusively on neuroscience, CEO Richard Pops said it will look externally to build its pipeline.

Human brain activity with plexus lines. External cerebral connections in the frontal lobe.
Alkermes is focused entirely on central nervous system diseases going forward • Source: Shutterstock

More from Strategy

More from Conferences